nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Hypogeusia—Varenicline—nicotine dependence	0.0409	0.0895	CcSEcCtD
Pazopanib—Blood calcium decreased—Varenicline—nicotine dependence	0.0313	0.0684	CcSEcCtD
Pazopanib—Haematochezia—Varenicline—nicotine dependence	0.0176	0.0386	CcSEcCtD
Pazopanib—Rash generalised—Varenicline—nicotine dependence	0.0167	0.0365	CcSEcCtD
Pazopanib—MAP3K9—midbrain—nicotine dependence	0.0144	0.0418	CbGeAlD
Pazopanib—Transient ischaemic attack—Varenicline—nicotine dependence	0.0141	0.0308	CcSEcCtD
Pazopanib—SH2B3—cardiovascular system—nicotine dependence	0.013	0.0378	CbGeAlD
Pazopanib—Platelet count decreased—Varenicline—nicotine dependence	0.0119	0.0261	CcSEcCtD
Pazopanib—PIP4K2C—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0116	0.0583	CbGpPWpGaD
Pazopanib—TAOK1—midbrain—nicotine dependence	0.0108	0.0314	CbGeAlD
Pazopanib—Cyst—Varenicline—nicotine dependence	0.0106	0.0232	CcSEcCtD
Pazopanib—Haematemesis—Varenicline—nicotine dependence	0.0102	0.0224	CcSEcCtD
Pazopanib—SH2B3—midbrain—nicotine dependence	0.0101	0.0295	CbGeAlD
Pazopanib—Thrombosis—Varenicline—nicotine dependence	0.01	0.0219	CcSEcCtD
Pazopanib—Menorrhagia—Varenicline—nicotine dependence	0.00959	0.021	CcSEcCtD
Pazopanib—MAP3K9—brain—nicotine dependence	0.00902	0.0263	CbGeAlD
Pazopanib—Rhinorrhoea—Varenicline—nicotine dependence	0.00876	0.0192	CcSEcCtD
Pazopanib—Dysphonia—Varenicline—nicotine dependence	0.00863	0.0189	CcSEcCtD
Pazopanib—Endocrine disorder—Varenicline—nicotine dependence	0.00856	0.0187	CcSEcCtD
Pazopanib—RIOK2—midbrain—nicotine dependence	0.00849	0.0247	CbGeAlD
Pazopanib—FGFR3—midbrain—nicotine dependence	0.00849	0.0247	CbGeAlD
Pazopanib—FLT4—cardiovascular system—nicotine dependence	0.00849	0.0247	CbGeAlD
Pazopanib—FGF1—cardiovascular system—nicotine dependence	0.00754	0.0219	CbGeAlD
Pazopanib—PI4KB—midbrain—nicotine dependence	0.00751	0.0219	CbGeAlD
Pazopanib—PIP4K2C—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00724	0.0363	CbGpPWpGaD
Pazopanib—Musculoskeletal pain—Varenicline—nicotine dependence	0.00718	0.0157	CcSEcCtD
Pazopanib—FGFR2—cardiovascular system—nicotine dependence	0.00712	0.0207	CbGeAlD
Pazopanib—Blood pressure increased—Varenicline—nicotine dependence	0.0071	0.0155	CcSEcCtD
Pazopanib—Pulmonary embolism—Varenicline—nicotine dependence	0.0071	0.0155	CcSEcCtD
Pazopanib—PIP4K2C—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00694	0.0348	CbGpPWpGaD
Pazopanib—TAOK1—brain—nicotine dependence	0.00677	0.0197	CbGeAlD
Pazopanib—FLT1—cardiovascular system—nicotine dependence	0.0066	0.0192	CbGeAlD
Pazopanib—PIP4K2C—midbrain—nicotine dependence	0.00659	0.0192	CbGeAlD
Pazopanib—FGFR1—midbrain—nicotine dependence	0.00654	0.019	CbGeAlD
Pazopanib—Mouth ulceration—Varenicline—nicotine dependence	0.00642	0.014	CcSEcCtD
Pazopanib—SH2B3—brain—nicotine dependence	0.00638	0.0186	CbGeAlD
Pazopanib—SH2B3—TCR Signaling Pathway—OPRM1—nicotine dependence	0.00632	0.0317	CbGpPWpGaD
Pazopanib—AURKC—brain—nicotine dependence	0.00628	0.0183	CbGeAlD
Pazopanib—STK10—cardiovascular system—nicotine dependence	0.00625	0.0182	CbGeAlD
Pazopanib—TAOK3—cardiovascular system—nicotine dependence	0.00622	0.0181	CbGeAlD
Pazopanib—PDGFRA—cardiovascular system—nicotine dependence	0.00618	0.018	CbGeAlD
Pazopanib—FGF1—midbrain—nicotine dependence	0.00589	0.0171	CbGeAlD
Pazopanib—PLK4—brain—nicotine dependence	0.00574	0.0167	CbGeAlD
Pazopanib—KDR—cardiovascular system—nicotine dependence	0.00558	0.0162	CbGeAlD
Pazopanib—MAP2K5—cardiovascular system—nicotine dependence	0.00558	0.0162	CbGeAlD
Pazopanib—Hot flush—Varenicline—nicotine dependence	0.00551	0.0121	CcSEcCtD
Pazopanib—Menopausal symptoms—Varenicline—nicotine dependence	0.00546	0.0119	CcSEcCtD
Pazopanib—CSF1R—cardiovascular system—nicotine dependence	0.00544	0.0159	CbGeAlD
Pazopanib—STK16—brain—nicotine dependence	0.00542	0.0158	CbGeAlD
Pazopanib—LYN—brain—nicotine dependence	0.00537	0.0156	CbGeAlD
Pazopanib—FGFR3—brain—nicotine dependence	0.00534	0.0155	CbGeAlD
Pazopanib—RIOK2—brain—nicotine dependence	0.00534	0.0155	CbGeAlD
Pazopanib—MAP3K19—brain—nicotine dependence	0.00528	0.0154	CbGeAlD
Pazopanib—BMPR1B—brain—nicotine dependence	0.00528	0.0154	CbGeAlD
Pazopanib—Cerebrovascular accident—Varenicline—nicotine dependence	0.00526	0.0115	CcSEcCtD
Pazopanib—Lethargy—Varenicline—nicotine dependence	0.00526	0.0115	CcSEcCtD
Pazopanib—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00521	0.0261	CbGpPWpGaD
Pazopanib—FLT1—midbrain—nicotine dependence	0.00515	0.015	CbGeAlD
Pazopanib—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00515	0.0113	CcSEcCtD
Pazopanib—EPHB6—midbrain—nicotine dependence	0.00509	0.0148	CbGeAlD
Pazopanib—KIT—cardiovascular system—nicotine dependence	0.00494	0.0144	CbGeAlD
Pazopanib—TAOK3—midbrain—nicotine dependence	0.00486	0.0141	CbGeAlD
Pazopanib—PDGFRB—cardiovascular system—nicotine dependence	0.00483	0.0141	CbGeAlD
Pazopanib—STK36—brain—nicotine dependence	0.00479	0.014	CbGeAlD
Pazopanib—Liver function test abnormal—Varenicline—nicotine dependence	0.00476	0.0104	CcSEcCtD
Pazopanib—Dry skin—Varenicline—nicotine dependence	0.00472	0.0103	CcSEcCtD
Pazopanib—PI4KB—brain—nicotine dependence	0.00472	0.0137	CbGeAlD
Pazopanib—Abdominal pain upper—Varenicline—nicotine dependence	0.00471	0.0103	CcSEcCtD
Pazopanib—Breast disorder—Varenicline—nicotine dependence	0.00466	0.0102	CcSEcCtD
Pazopanib—LIMK2—brain—nicotine dependence	0.00463	0.0135	CbGeAlD
Pazopanib—Nasopharyngitis—Varenicline—nicotine dependence	0.00461	0.0101	CcSEcCtD
Pazopanib—Abdominal distension—Varenicline—nicotine dependence	0.00448	0.00981	CcSEcCtD
Pazopanib—KDR—midbrain—nicotine dependence	0.00436	0.0127	CbGeAlD
Pazopanib—MAP2K5—midbrain—nicotine dependence	0.00436	0.0127	CbGeAlD
Pazopanib—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00428	0.0214	CbGpPWpGaD
Pazopanib—CSF1R—midbrain—nicotine dependence	0.00425	0.0124	CbGeAlD
Pazopanib—FLT4—brain—nicotine dependence	0.00417	0.0121	CbGeAlD
Pazopanib—PIP4K2C—brain—nicotine dependence	0.00414	0.0121	CbGeAlD
Pazopanib—FGFR1—brain—nicotine dependence	0.00411	0.012	CbGeAlD
Pazopanib—ITK—TCR Signaling Pathway—OPRM1—nicotine dependence	0.00407	0.0204	CbGpPWpGaD
Pazopanib—Photosensitivity reaction—Varenicline—nicotine dependence	0.00406	0.00889	CcSEcCtD
Pazopanib—Infestation NOS—Varenicline—nicotine dependence	0.00397	0.00869	CcSEcCtD
Pazopanib—Infestation—Varenicline—nicotine dependence	0.00397	0.00869	CcSEcCtD
Pazopanib—MAP3K2—brain—nicotine dependence	0.00393	0.0114	CbGeAlD
Pazopanib—Acute coronary syndrome—Varenicline—nicotine dependence	0.00391	0.00856	CcSEcCtD
Pazopanib—Myocardial infarction—Varenicline—nicotine dependence	0.00389	0.00852	CcSEcCtD
Pazopanib—Stomatitis—Varenicline—nicotine dependence	0.00387	0.00847	CcSEcCtD
Pazopanib—KIT—midbrain—nicotine dependence	0.00386	0.0112	CbGeAlD
Pazopanib—FLT4—Signaling by VEGF—WASF2—nicotine dependence	0.00382	0.0191	CbGpPWpGaD
Pazopanib—PDGFRB—midbrain—nicotine dependence	0.00377	0.011	CbGeAlD
Pazopanib—Hepatobiliary disease—Varenicline—nicotine dependence	0.00375	0.00822	CcSEcCtD
Pazopanib—Epistaxis—Varenicline—nicotine dependence	0.00374	0.00819	CcSEcCtD
Pazopanib—FGF1—brain—nicotine dependence	0.0037	0.0108	CbGeAlD
Pazopanib—FLT4—Signaling by VEGF—WASF1—nicotine dependence	0.00366	0.0183	CbGpPWpGaD
Pazopanib—Bradycardia—Varenicline—nicotine dependence	0.00363	0.00794	CcSEcCtD
Pazopanib—Hypoaesthesia—Varenicline—nicotine dependence	0.00355	0.00776	CcSEcCtD
Pazopanib—Urinary tract disorder—Varenicline—nicotine dependence	0.00352	0.0077	CcSEcCtD
Pazopanib—Oedema peripheral—Varenicline—nicotine dependence	0.00351	0.00768	CcSEcCtD
Pazopanib—Connective tissue disorder—Varenicline—nicotine dependence	0.0035	0.00766	CcSEcCtD
Pazopanib—FGFR2—brain—nicotine dependence	0.00349	0.0102	CbGeAlD
Pazopanib—Urethral disorder—Varenicline—nicotine dependence	0.00349	0.00764	CcSEcCtD
Pazopanib—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00334	0.0167	CbGpPWpGaD
Pazopanib—Eye disorder—Varenicline—nicotine dependence	0.00333	0.00729	CcSEcCtD
Pazopanib—Cardiac disorder—Varenicline—nicotine dependence	0.00331	0.00724	CcSEcCtD
Pazopanib—FLT1—brain—nicotine dependence	0.00324	0.00943	CbGeAlD
Pazopanib—Angiopathy—Varenicline—nicotine dependence	0.00323	0.00708	CcSEcCtD
Pazopanib—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00323	0.0162	CbGpPWpGaD
Pazopanib—Mediastinal disorder—Varenicline—nicotine dependence	0.00321	0.00703	CcSEcCtD
Pazopanib—EPHB6—brain—nicotine dependence	0.0032	0.00932	CbGeAlD
Pazopanib—Chills—Varenicline—nicotine dependence	0.0032	0.007	CcSEcCtD
Pazopanib—MAP3K2—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00316	0.0158	CbGpPWpGaD
Pazopanib—Mental disorder—Varenicline—nicotine dependence	0.00312	0.00683	CcSEcCtD
Pazopanib—Erythema—Varenicline—nicotine dependence	0.0031	0.00679	CcSEcCtD
Pazopanib—Malnutrition—Varenicline—nicotine dependence	0.0031	0.00679	CcSEcCtD
Pazopanib—STK10—brain—nicotine dependence	0.00307	0.00893	CbGeAlD
Pazopanib—Flatulence—Varenicline—nicotine dependence	0.00306	0.00669	CcSEcCtD
Pazopanib—TAOK3—brain—nicotine dependence	0.00305	0.00889	CbGeAlD
Pazopanib—Dysgeusia—Varenicline—nicotine dependence	0.00304	0.00665	CcSEcCtD
Pazopanib—PDGFRA—brain—nicotine dependence	0.00303	0.00884	CbGeAlD
Pazopanib—Muscle spasms—Varenicline—nicotine dependence	0.00298	0.00653	CcSEcCtD
Pazopanib—Vision blurred—Varenicline—nicotine dependence	0.00292	0.0064	CcSEcCtD
Pazopanib—Anaemia—Varenicline—nicotine dependence	0.00287	0.00627	CcSEcCtD
Pazopanib—FLT1—Signaling by VEGF—WASF2—nicotine dependence	0.00285	0.0143	CbGpPWpGaD
Pazopanib—FGFR3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00284	0.0142	CbGpPWpGaD
Pazopanib—Syncope—Varenicline—nicotine dependence	0.00278	0.00609	CcSEcCtD
Pazopanib—KDR—brain—nicotine dependence	0.00274	0.00797	CbGeAlD
Pazopanib—MAP2K5—brain—nicotine dependence	0.00274	0.00797	CbGeAlD
Pazopanib—FLT1—Signaling by VEGF—WASF1—nicotine dependence	0.00273	0.0137	CbGpPWpGaD
Pazopanib—Loss of consciousness—Varenicline—nicotine dependence	0.00273	0.00597	CcSEcCtD
Pazopanib—Cough—Varenicline—nicotine dependence	0.00271	0.00592	CcSEcCtD
Pazopanib—Hypertension—Varenicline—nicotine dependence	0.00268	0.00586	CcSEcCtD
Pazopanib—CSF1R—brain—nicotine dependence	0.00267	0.00778	CbGeAlD
Pazopanib—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00265	0.0133	CbGpPWpGaD
Pazopanib—Myalgia—Varenicline—nicotine dependence	0.00264	0.00578	CcSEcCtD
Pazopanib—Chest pain—Varenicline—nicotine dependence	0.00264	0.00578	CcSEcCtD
Pazopanib—Arthralgia—Varenicline—nicotine dependence	0.00264	0.00578	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00262	0.00574	CcSEcCtD
Pazopanib—Dry mouth—Varenicline—nicotine dependence	0.00258	0.00565	CcSEcCtD
Pazopanib—Oedema—Varenicline—nicotine dependence	0.00253	0.00554	CcSEcCtD
Pazopanib—Infection—Varenicline—nicotine dependence	0.00252	0.0055	CcSEcCtD
Pazopanib—Shock—Varenicline—nicotine dependence	0.00249	0.00545	CcSEcCtD
Pazopanib—Nervous system disorder—Varenicline—nicotine dependence	0.00248	0.00543	CcSEcCtD
Pazopanib—Thrombocytopenia—Varenicline—nicotine dependence	0.00248	0.00542	CcSEcCtD
Pazopanib—Skin disorder—Varenicline—nicotine dependence	0.00246	0.00538	CcSEcCtD
Pazopanib—Hyperhidrosis—Varenicline—nicotine dependence	0.00245	0.00536	CcSEcCtD
Pazopanib—KIT—brain—nicotine dependence	0.00243	0.00706	CbGeAlD
Pazopanib—Anorexia—Varenicline—nicotine dependence	0.00241	0.00528	CcSEcCtD
Pazopanib—PDGFRB—brain—nicotine dependence	0.00237	0.0069	CbGeAlD
Pazopanib—FGF1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00236	0.0118	CbGpPWpGaD
Pazopanib—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00231	0.00505	CcSEcCtD
Pazopanib—Insomnia—Varenicline—nicotine dependence	0.00229	0.00501	CcSEcCtD
Pazopanib—Dyspnoea—Varenicline—nicotine dependence	0.00226	0.00494	CcSEcCtD
Pazopanib—Somnolence—Varenicline—nicotine dependence	0.00225	0.00493	CcSEcCtD
Pazopanib—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00225	0.0113	CbGpPWpGaD
Pazopanib—Dyspepsia—Varenicline—nicotine dependence	0.00223	0.00488	CcSEcCtD
Pazopanib—Decreased appetite—Varenicline—nicotine dependence	0.0022	0.00482	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00219	0.00478	CcSEcCtD
Pazopanib—Fatigue—Varenicline—nicotine dependence	0.00218	0.00478	CcSEcCtD
Pazopanib—Pain—Varenicline—nicotine dependence	0.00217	0.00474	CcSEcCtD
Pazopanib—ABCG2—midbrain—nicotine dependence	0.00212	0.00617	CbGeAlD
Pazopanib—MAP2K5—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00209	0.0105	CbGpPWpGaD
Pazopanib—Gastrointestinal pain—Varenicline—nicotine dependence	0.00207	0.00453	CcSEcCtD
Pazopanib—KDR—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00201	0.0101	CbGpPWpGaD
Pazopanib—Abdominal pain—Varenicline—nicotine dependence	0.002	0.00438	CcSEcCtD
Pazopanib—FGFR2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00195	0.00979	CbGpPWpGaD
Pazopanib—KDR—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00192	0.00964	CbGpPWpGaD
Pazopanib—KDR—Signaling by VEGF—WASF2—nicotine dependence	0.00189	0.00949	CbGpPWpGaD
Pazopanib—FGFR1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00182	0.00912	CbGpPWpGaD
Pazopanib—Asthenia—Varenicline—nicotine dependence	0.00182	0.00398	CcSEcCtD
Pazopanib—KDR—Signaling by VEGF—WASF1—nicotine dependence	0.00182	0.0091	CbGpPWpGaD
Pazopanib—PDGFRA—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00182	0.0091	CbGpPWpGaD
Pazopanib—Pruritus—Varenicline—nicotine dependence	0.00179	0.00392	CcSEcCtD
Pazopanib—FGFR3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00177	0.00886	CbGpPWpGaD
Pazopanib—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00173	0.00869	CbGpPWpGaD
Pazopanib—Diarrhoea—Varenicline—nicotine dependence	0.00173	0.00379	CcSEcCtD
Pazopanib—FGFR3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00169	0.00849	CbGpPWpGaD
Pazopanib—FGFR3—Signaling by NGF—FGD1—nicotine dependence	0.00169	0.00845	CbGpPWpGaD
Pazopanib—Dizziness—Varenicline—nicotine dependence	0.00167	0.00366	CcSEcCtD
Pazopanib—PDGFRB—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00164	0.0082	CbGpPWpGaD
Pazopanib—LYN—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—nicotine dependence	0.00162	0.00813	CbGpPWpGaD
Pazopanib—Vomiting—Varenicline—nicotine dependence	0.00161	0.00352	CcSEcCtD
Pazopanib—Rash—Varenicline—nicotine dependence	0.0016	0.00349	CcSEcCtD
Pazopanib—Dermatitis—Varenicline—nicotine dependence	0.0016	0.00349	CcSEcCtD
Pazopanib—Headache—Varenicline—nicotine dependence	0.00159	0.00347	CcSEcCtD
Pazopanib—LYN—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.00156	0.0078	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling by NGF—FGD1—nicotine dependence	0.00151	0.00755	CbGpPWpGaD
Pazopanib—Nausea—Varenicline—nicotine dependence	0.0015	0.00329	CcSEcCtD
Pazopanib—FGF1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00147	0.00736	CbGpPWpGaD
Pazopanib—FGF1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00141	0.00706	CbGpPWpGaD
Pazopanib—FGF1—Signaling by NGF—FGD1—nicotine dependence	0.0014	0.00702	CbGpPWpGaD
Pazopanib—CYP2C8—brain—nicotine dependence	0.00137	0.00399	CbGeAlD
Pazopanib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00134	0.00672	CbGpPWpGaD
Pazopanib—ABCB1—cardiovascular system—nicotine dependence	0.00134	0.0039	CbGeAlD
Pazopanib—ABCG2—brain—nicotine dependence	0.00133	0.00388	CbGeAlD
Pazopanib—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00132	0.00664	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—TAS2R16—nicotine dependence	0.00128	0.0064	CbGpPWpGaD
Pazopanib—FGFR2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00122	0.00609	CbGpPWpGaD
Pazopanib—PDGFRB—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00117	0.00587	CbGpPWpGaD
Pazopanib—FGFR2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00117	0.00584	CbGpPWpGaD
Pazopanib—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00116	0.00583	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—FGD1—nicotine dependence	0.00116	0.00581	CbGpPWpGaD
Pazopanib—LYN—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00115	0.00575	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—FGD1—nicotine dependence	0.00114	0.00571	CbGpPWpGaD
Pazopanib—FGFR1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00113	0.00568	CbGpPWpGaD
Pazopanib—PDGFRA—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00113	0.00566	CbGpPWpGaD
Pazopanib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0011	0.00552	CbGpPWpGaD
Pazopanib—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.0011	0.0055	CbGpPWpGaD
Pazopanib—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00109	0.00545	CbGpPWpGaD
Pazopanib—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00109	0.00545	CbGpPWpGaD
Pazopanib—FGFR1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00109	0.00544	CbGpPWpGaD
Pazopanib—PDGFRA—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00108	0.00543	CbGpPWpGaD
Pazopanib—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00108	0.00542	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—FGD1—nicotine dependence	0.00108	0.00542	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—FGD1—nicotine dependence	0.00108	0.0054	CbGpPWpGaD
Pazopanib—ITK—Innate Immune System—WASF2—nicotine dependence	0.00107	0.00535	CbGpPWpGaD
Pazopanib—ABCB1—midbrain—nicotine dependence	0.00105	0.00304	CbGeAlD
Pazopanib—ITK—Innate Immune System—WASF1—nicotine dependence	0.00102	0.00513	CbGpPWpGaD
Pazopanib—PDGFRB—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00102	0.0051	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—FGD1—nicotine dependence	0.001	0.00502	CbGpPWpGaD
Pazopanib—PDGFRB—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000976	0.00489	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—FGD1—nicotine dependence	0.000971	0.00487	CbGpPWpGaD
Pazopanib—LCK—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00094	0.00471	CbGpPWpGaD
Pazopanib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000933	0.00468	CbGpPWpGaD
Pazopanib—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000921	0.00462	CbGpPWpGaD
Pazopanib—CYP2D6—brain—nicotine dependence	0.000913	0.00266	CbGeAlD
Pazopanib—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000893	0.00448	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—AKR1B10—nicotine dependence	0.000885	0.00444	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000885	0.00444	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—CYP2A7—nicotine dependence	0.000837	0.00419	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—TAS2R16—nicotine dependence	0.00081	0.00406	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—FGD1—nicotine dependence	0.000779	0.00391	CbGpPWpGaD
Pazopanib—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000756	0.00379	CbGpPWpGaD
Pazopanib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00072	0.00361	CbGpPWpGaD
Pazopanib—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000711	0.00356	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—FGD1—nicotine dependence	0.000695	0.00348	CbGpPWpGaD
Pazopanib—ABCB1—brain—nicotine dependence	0.000657	0.00191	CbGeAlD
Pazopanib—FLT4—Signaling Pathways—FGD1—nicotine dependence	0.000635	0.00318	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—WASF2—nicotine dependence	0.000624	0.00313	CbGpPWpGaD
Pazopanib—ITK—Immune System—WASF2—nicotine dependence	0.000622	0.00312	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000614	0.00308	CbGpPWpGaD
Pazopanib—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000613	0.00307	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TAS2R16—nicotine dependence	0.000604	0.00303	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—WASF2—nicotine dependence	0.000598	0.003	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—WASF1—nicotine dependence	0.000598	0.003	CbGpPWpGaD
Pazopanib—ITK—Immune System—WASF1—nicotine dependence	0.000596	0.00299	CbGpPWpGaD
Pazopanib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000584	0.00293	CbGpPWpGaD
Pazopanib—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000578	0.0029	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—WASF1—nicotine dependence	0.000574	0.00287	CbGpPWpGaD
Pazopanib—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00057	0.00286	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—AKR1B10—nicotine dependence	0.000561	0.00281	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—OPRM1—nicotine dependence	0.000538	0.0027	CbGpPWpGaD
Pazopanib—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000503	0.00252	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—WASF2—nicotine dependence	0.000497	0.00249	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—WASF1—nicotine dependence	0.000477	0.00239	CbGpPWpGaD
Pazopanib—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000474	0.00238	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—FGD1—nicotine dependence	0.000474	0.00238	CbGpPWpGaD
Pazopanib—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000468	0.00234	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TAS2R16—nicotine dependence	0.000461	0.00231	CbGpPWpGaD
Pazopanib—FGFR3—Disease—AKR1B10—nicotine dependence	0.000457	0.00229	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—WASF2—nicotine dependence	0.000432	0.00217	CbGpPWpGaD
Pazopanib—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000426	0.00214	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—AKR1B10—nicotine dependence	0.000419	0.0021	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—WASF1—nicotine dependence	0.000414	0.00208	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TAS2R16—nicotine dependence	0.000412	0.00207	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—WASF2—nicotine dependence	0.000411	0.00206	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—WASF2—nicotine dependence	0.000404	0.00203	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TAS2R16—nicotine dependence	0.000402	0.00201	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000402	0.00201	CbGpPWpGaD
Pazopanib—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000396	0.00199	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—WASF2—nicotine dependence	0.000395	0.00198	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—WASF1—nicotine dependence	0.000394	0.00198	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—DRD2—nicotine dependence	0.000389	0.00195	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—WASF1—nicotine dependence	0.000387	0.00194	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—WASF2—nicotine dependence	0.000384	0.00192	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TAS2R16—nicotine dependence	0.000383	0.00192	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—WASF2—nicotine dependence	0.000383	0.00192	CbGpPWpGaD
Pazopanib—FGF1—Disease—AKR1B10—nicotine dependence	0.000379	0.0019	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—WASF1—nicotine dependence	0.000379	0.0019	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—OPRM1—nicotine dependence	0.000373	0.00187	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—WASF1—nicotine dependence	0.000368	0.00184	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000367	0.00184	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—WASF1—nicotine dependence	0.000367	0.00184	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—FGD1—nicotine dependence	0.000362	0.00181	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—WASF2—nicotine dependence	0.000348	0.00175	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—WASF2—nicotine dependence	0.000345	0.00173	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—OPRM1—nicotine dependence	0.000341	0.00171	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00034	0.0017	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—WASF2—nicotine dependence	0.000337	0.00169	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—WASF1—nicotine dependence	0.000334	0.00167	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—WASF1—nicotine dependence	0.00033	0.00166	CbGpPWpGaD
Pazopanib—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000329	0.00165	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—FGD1—nicotine dependence	0.000324	0.00162	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—WASF1—nicotine dependence	0.000323	0.00162	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKR1B10—nicotine dependence	0.00032	0.0016	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TAS2R16—nicotine dependence	0.000317	0.00159	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—FGD1—nicotine dependence	0.000315	0.00158	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKR1B10—nicotine dependence	0.000314	0.00157	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TAS2R16—nicotine dependence	0.000312	0.00156	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00031	0.00155	CbGpPWpGaD
Pazopanib—KIT—Disease—AKR1B10—nicotine dependence	0.000308	0.00155	CbGpPWpGaD
Pazopanib—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000306	0.00153	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—FGD1—nicotine dependence	0.000301	0.00151	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TAS2R16—nicotine dependence	0.000296	0.00148	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TAS2R16—nicotine dependence	0.000295	0.00148	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—WASF2—nicotine dependence	0.000295	0.00148	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKR1B10—nicotine dependence	0.000293	0.00147	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKR1B10—nicotine dependence	0.000292	0.00146	CbGpPWpGaD
Pazopanib—FGF1—Immune System—WASF2—nicotine dependence	0.00029	0.00145	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKR1B10—nicotine dependence	0.000286	0.00143	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—WASF1—nicotine dependence	0.000283	0.00142	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKR1B10—nicotine dependence	0.000279	0.0014	CbGpPWpGaD
Pazopanib—FGF1—Immune System—WASF1—nicotine dependence	0.000278	0.00139	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—WASF2—nicotine dependence	0.000277	0.00139	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—DRD2—nicotine dependence	0.00027	0.00135	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKR1B10—nicotine dependence	0.000266	0.00133	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TAS2R16—nicotine dependence	0.000266	0.00133	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—WASF1—nicotine dependence	0.000265	0.00133	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKR1B10—nicotine dependence	0.000263	0.00132	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TAS2R16—nicotine dependence	0.00026	0.0013	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—OPRM1—nicotine dependence	0.000255	0.00128	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—FGD1—nicotine dependence	0.000249	0.00125	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—DRD2—nicotine dependence	0.000247	0.00124	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—FGD1—nicotine dependence	0.000245	0.00123	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—WASF2—nicotine dependence	0.00024	0.0012	CbGpPWpGaD
Pazopanib—KIT—Immune System—WASF2—nicotine dependence	0.000235	0.00118	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—FGD1—nicotine dependence	0.000232	0.00116	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—FGD1—nicotine dependence	0.000231	0.00116	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—WASF1—nicotine dependence	0.00023	0.00115	CbGpPWpGaD
Pazopanib—KIT—Immune System—WASF1—nicotine dependence	0.000226	0.00113	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—WASF2—nicotine dependence	0.000225	0.00113	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—WASF2—nicotine dependence	0.000223	0.00112	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—WASF2—nicotine dependence	0.000223	0.00112	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKR1B10—nicotine dependence	0.00022	0.0011	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKR1B10—nicotine dependence	0.000216	0.00108	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—WASF1—nicotine dependence	0.000216	0.00108	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—WASF1—nicotine dependence	0.000214	0.00107	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—WASF1—nicotine dependence	0.000214	0.00107	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TAS2R16—nicotine dependence	0.000213	0.00107	CbGpPWpGaD
Pazopanib—LCK—Disease—AKR1B10—nicotine dependence	0.000211	0.00106	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—FGD1—nicotine dependence	0.000209	0.00105	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKR1B10—nicotine dependence	0.000205	0.00103	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKR1B10—nicotine dependence	0.000204	0.00102	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—FGD1—nicotine dependence	0.000204	0.00102	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—WASF2—nicotine dependence	0.000201	0.00101	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—WASF2—nicotine dependence	0.000201	0.00101	CbGpPWpGaD
Pazopanib—LYN—Immune System—WASF2—nicotine dependence	0.000197	0.000985	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—WASF2—nicotine dependence	0.000196	0.000984	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—OPRM1—nicotine dependence	0.000194	0.000975	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—WASF1—nicotine dependence	0.000193	0.000968	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—WASF1—nicotine dependence	0.000192	0.000965	CbGpPWpGaD
Pazopanib—LYN—Immune System—WASF1—nicotine dependence	0.000188	0.000944	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—WASF1—nicotine dependence	0.000188	0.000943	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.000188	0.000941	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—WASF2—nicotine dependence	0.000187	0.000938	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKR1B10—nicotine dependence	0.000184	0.000923	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—DRD2—nicotine dependence	0.000184	0.000923	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000184	0.000921	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKR1B10—nicotine dependence	0.00018	0.000904	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—WASF1—nicotine dependence	0.000179	0.0009	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—OPRM1—nicotine dependence	0.000174	0.000871	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	0.000172	0.000862	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—OPRM1—nicotine dependence	0.000169	0.000849	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FGD1—nicotine dependence	0.000167	0.000839	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—OPRM1—nicotine dependence	0.000162	0.00081	CbGpPWpGaD
Pazopanib—LCK—Immune System—WASF2—nicotine dependence	0.000161	0.000807	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000159	0.000798	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—WASF2—nicotine dependence	0.000155	0.000777	CbGpPWpGaD
Pazopanib—LCK—Immune System—WASF1—nicotine dependence	0.000154	0.000774	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—WASF2—nicotine dependence	0.000152	0.000763	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—WASF1—nicotine dependence	0.000149	0.000745	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKR1B10—nicotine dependence	0.000148	0.000741	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—WASF1—nicotine dependence	0.000146	0.000731	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—WASF2—nicotine dependence	0.000144	0.000724	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—WASF2—nicotine dependence	0.000144	0.000722	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—DRD2—nicotine dependence	0.000141	0.000705	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—WASF1—nicotine dependence	0.000138	0.000694	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—WASF1—nicotine dependence	0.000138	0.000692	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—OPRM1—nicotine dependence	0.000134	0.00067	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—OPRM1—nicotine dependence	0.000131	0.000658	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—WASF2—nicotine dependence	0.00013	0.00065	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—WASF2—nicotine dependence	0.000127	0.000637	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—DRD2—nicotine dependence	0.000126	0.00063	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—OPRM1—nicotine dependence	0.000125	0.000625	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—WASF1—nicotine dependence	0.000124	0.000624	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—OPRM1—nicotine dependence	0.000124	0.000623	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—DRD2—nicotine dependence	0.000122	0.000614	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—WASF1—nicotine dependence	0.000122	0.000611	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—DRD2—nicotine dependence	0.000117	0.000586	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—OPRM1—nicotine dependence	0.000112	0.000562	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—OPRM1—nicotine dependence	0.00011	0.00055	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—WASF2—nicotine dependence	0.000104	0.000522	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—WASF1—nicotine dependence	9.98e-05	0.0005	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CYP2A7—nicotine dependence	9.88e-05	0.000495	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—DRD2—nicotine dependence	9.67e-05	0.000485	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—DRD2—nicotine dependence	9.5e-05	0.000476	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD2—nicotine dependence	9.01e-05	0.000452	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD2—nicotine dependence	8.99e-05	0.000451	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—OPRM1—nicotine dependence	8.99e-05	0.000451	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP2A7—nicotine dependence	8.61e-05	0.000431	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP2A7—nicotine dependence	8.11e-05	0.000407	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD2—nicotine dependence	8.1e-05	0.000406	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD2—nicotine dependence	7.93e-05	0.000397	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP2A7—nicotine dependence	6.87e-05	0.000344	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD2—nicotine dependence	6.5e-05	0.000326	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2A7—nicotine dependence	5.3e-05	0.000266	CbGpPWpGaD
